KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2016 - 2025)

Acadia Pharmaceuticals has reported Amortizatization of Intangibles over the past 15 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $2.7 million for Q4 2025, down 3.37% from a year ago — trailing twelve months through Dec 2025 was $10.2 million (down 19.4% YoY), and the annual figure for FY2025 was $10.9 million, up 17.04%.
  • Amortizatization of Intangibles for Q4 2025 was $2.7 million at Acadia Pharmaceuticals, up from $2.7 million in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for ACAD hit a ceiling of $5.3 million in Q1 2024 and a floor of -$3.5 million in Q4 2021.
  • Median Amortizatization of Intangibles over the past 5 years was $1.4 million (2023), compared with a mean of $1.5 million.
  • Biggest five-year swings in Amortizatization of Intangibles: tumbled 995.92% in 2021 and later soared 848.44% in 2023.
  • Acadia Pharmaceuticals' Amortizatization of Intangibles stood at -$3.5 million in 2021, then surged by 81.72% to -$642000.0 in 2022, then soared by 848.44% to $4.8 million in 2023, then crashed by 41.37% to $2.8 million in 2024, then fell by 3.37% to $2.7 million in 2025.
  • The last three reported values for Amortizatization of Intangibles were $2.7 million (Q4 2025), $2.7 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.